Michael Klichinsky
Chief Scientific Officer at Carisma Therapeutics Inc. (CARM) since March 2023
Michael Klichinsky has filed 8 insider reports with the SEC since March 2023, as chief Scientific Officer at Carisma Therapeutics Inc. (CARM). Michael Klichinsky made no open-market purchases or sales in the last 12 months. In the latest filing, on October 8, 2025, Michael Klichinsky sold 56,982 shares of Carisma Therapeutics Inc. (CARM) for $14.5K at an average of $0.25.
- Filings
- 8
- Companies
- 1
- Bought on market
- None
- Sold on market
- $139K
Companies where Michael Klichinsky is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Scientific Officersince March 2023 | 0 | $139K | Oct 8, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Oct 7, 2025-$14.5KCARMChief Scientific Officer Klichinsky Michael exercised 56,982 shares at a strike of $0.11 and sold $14,485 worth of shares (56,982 units at $0.25)Form 4Exercise or conversion of a derivativeOpen-market sale
- Oct 3, 2025-$124KCARMChief Scientific Officer Klichinsky Michael sold $124,343 worth of shares (484,347 units at $0.26), closing all direct ownership in the companyForm 4Open-market sale
- Jan 28, 2025CARMSEC Form 4 filed by Chief Scientific Officer Klichinsky MichaelForm 4Grant or award
- Jun 17, 2024CARMSEC Form 4 filed by Chief Scientific Officer Klichinsky MichaelForm 4Grant or award
- Jan 31, 2024CARMSEC Form 4 filed by Klichinsky MichaelForm 4Grant or award
- Jun 6, 2023CARMSEC Form 4 filed by Klichinsky MichaelForm 4Grant or award
- Mar 7, 2023CARMSEC Form 4: Klichinsky Michael was granted 484,347 sharesForm 4Grant or award
- Mar 7, 2023CARMMichael Klichinsky became an insiderForm 3New insider
Compare Michael Klichinsky with
- Michael Klichinsky vs Steven Kelly1 shared
- Michael Klichinsky vs Natalie McAndrew1 shared
- Michael Klichinsky vs Sohanya Roshan Cheng1 shared
- Michael Klichinsky vs Marella Thorell1 shared
- Michael Klichinsky vs David Scadden1 shared
- Michael Klichinsky vs Sanford S Zweifach1 shared
Other insiders at the same companies
Questions about Michael Klichinsky
- What is Michael Klichinsky's role at Carisma Therapeutics Inc.?
- Michael Klichinsky reports to the SEC as chief Scientific Officer at Carisma Therapeutics Inc. (CARM), according to the latest filing on October 8, 2025.
- Has Michael Klichinsky bought or sold stock recently?
- The most recent open-market sale was on October 7, 2025: sold 56,982 shares of Carisma Therapeutics Inc. (CARM) for $14.5K at an average of $0.25.
- How do I get alerts when Michael Klichinsky files?
- Follow Michael Klichinsky on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael Klichinsky (SEC CIK 0001967221). Totals count each trade once, skipping amendments whose original is on file, from Mar 10, 2023 on. View on SEC EDGAR · Get this as JSON